Purchase Order 36C26224P1616

Award Date 6/18/24
Potential Completion Date 5/22/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $49,748.73 firm-fixed-price delivery order is for the provision of Novocure's Optune Plus transducer devices, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma in veteran patients. The award is part of a larger $28.85 million Federal...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Plus transducers, which deliver Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract is a firm-fixed-price purchase order with a period of performance...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $33,165.82 firm fixed-price delivery order contract is for the provision of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma. The contract is part of a larger $28.85 million Federal...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award, valued at $49,748.73, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's proprietary Optune Transducer, a device that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. The contract has a firm fixed price and an ultimate...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $16,582.91 firm fixed-price delivery order is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's mission of...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $16,582.91 firm fixed-price purchase order is for the delivery of Novocure's Optune transducer arrays, device rentals, and associated support services. Novocure's Optune system delivers alternating electric fields to disrupt solid tumor cancer cell division and is FDA-approved for the...
This federal contract award, valued at $33,165.82, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Novocure's Optune Plus system, which delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and mesothelioma. This is a firm-fixed-price purchase order with a period of performance running through...
This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, provides the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) with Optune Plus Transducers for the treatment of glioblastoma, mesothelioma, and other solid tumor cancers. The $16,582.91 firm fixed-price delivery order is part of a larger $28.85 million Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) that Novocure holds with the VA VHA. This FSS contract...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a $16,582.91 firm-fixed-price delivery order issued under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA. The order is for Novocure's Optune Plus transducers, device rentals, and related support services for the treatment of glioblastoma and...

This federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $33,165.82, is a firm fixed-price purchase order for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers such as glioblastoma and mesothelioma.

The contract does not have a set-aside designation, likely due to the specialized nature of Novocure's medical device offerings. Novocure acts as the prime contractor, delivering its proprietary Optune technology directly to VA medical centers nationwide without employing subcontractors. This contract is part of Novocure's larger Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with the VA VHA, valued at $28.85 million and running through October 31, 2027. The FSS contract serves as a primary procurement vehicle for the VA to obtain Novocure's innovative, non-invasive cancer treatment technologies.

Generated 5/23/25, 10:05 AM